34-year-old woman presents with recurrent episodes of severe lactic acidosis (lactate 12 mmol/L) triggered by febrile illnesses, but her acidosis paradoxically worsens when treated with high-dose thiamine, and improves when thiamine is withheld. Between episodes she is entirely asymptomatic with normal lactate. Her fibroblast studies show normal pyruvate dehydrogenase activity, normal respiratory chain complex assays, and normal pyruvate carboxylase. Whole-exome sequencing reveals a variant of uncertain significance in a gene encoding a mitochondrial transporter. Explain the precise biochemical mechanism by which thiamine administration could worsen lactic acidosis in a specific inherited disorder, and name the transporter/enzyme system involved. Why does the acidosis remit completely between crises?
Reading File
Finding Sources
Finding Sources
Finding Sources
Searching PubMed
thiamine worsens lactic acidosis mitochondrial transporter inherited
Finding Sources
Finding Sources
Searching PubMed
thiamine pyrophosphate mitochondria lactic acidosis paradox
Searching PubMed
SLC25A19 thiamine pyrophosphate mitochondrial carrier lactic acidosis
Finding Sources
Finding Sources
Searching PubMed
SLC25A19 deoxynucleotide carrier thiamine pyrophosphate lactic acidosis
Searching the Web
SLC25A19 thiamine pyrophosphate mitochondrial carrier lactic acidosis worsening thiamine treatment inherited disorder
Reading Web Page
https://www.ncbi.nlm.nih.gov/books/NBK1365
Searching PubMed
TPK1 thiamine pyrophosphokinase deficiency lactic acidosis episodic
Searching the Web
SLC25A19 TPP carrier deficiency why does thiamine worsen lactic acidosis mechanism osmotic cytosolic TPP increase paradox
Searching PubMed
SLC25A19 thiamine metabolism dysfunction syndrome episodic lactic acidosis fever
Searching the Web
"SLC25A19" OR "mitochondrial TPP carrier" thiamine supplementation worsens acidosis pyruvate dehydrogenase substrate overload mechanism
Reading Article
PMID: 25458521
I now have all the pieces I need for a comprehensive, mechanistically precise answer. Let me synthesize everything into a thorough response.
The question describes a very specific and sophisticated scenario. The key features are:
- Episodic severe lactic acidosis triggered by febrile illness
- Paradoxical worsening with high-dose thiamine
- Improvement when thiamine is withheld
- Normal PDH activity, normal respiratory chain complexes, normal pyruvate carboxylase
- WES variant in a mitochondrial transporter gene
- Complete clinical remission between episodes
This maps to SLC25A19 - the mitochondrial thiamine pyrophosphate (TPP) carrier. The paradoxical thiamine-worsening is the most intellectually novel element - let me now synthesize the precise mechanism.
The Disorder: SLC25A19 Deficiency (Thiamine Metabolism Dysfunction Syndrome, THMD3/4)
The transporter involved: SLC25A19 - the mitochondrial thiamine pyrophosphate carrier (MTPPT), a member of the SLC25 family of inner mitochondrial membrane transporters. It functions as an antiporter, exchanging cytosolic TPP for mitochondrial TMP (thiamine monophosphate) across the inner mitochondrial membrane.
Precise Biochemical Mechanism
Normal thiamine metabolism and the SLC25A19 transport cycle
- Dietary thiamine enters cells via SLC19A2/SLC19A3 plasma membrane transporters
- Intracellular thiamine is phosphorylated to TPP (thiamine pyrophosphate) by thiamine pyrophosphokinase (TPK1) in the cytosol
- Cytosolic TPP is the substrate for SLC25A19, which imports it into the mitochondrial matrix in exchange for mitochondrial TMP
- Inside the matrix, TPP serves as an obligate cofactor for three enzymes:
- Pyruvate dehydrogenase complex (PDHc) - pyruvate → acetyl-CoA
- alpha-ketoglutarate dehydrogenase (alpha-KGDH) - alpha-ketoglutarate → succinyl-CoA
- Branched-chain alpha-keto acid dehydrogenase (BCKDH)
Why standard enzyme assays are normal in this patient
The fibroblast assays that came back normal used exogenous, saturating concentrations of TPP added directly to the reaction mixture - this bypasses the transporter entirely. PDHc, alpha-KGDH, and respiratory chain complexes are structurally intact. The defect is upstream: the mutant SLC25A19 carrier cannot deliver adequate TPP into the mitochondrial matrix under conditions of metabolic stress, so the enzymes are normal in structure but starved of cofactor in vivo.
Why febrile illness triggers crisis
During fever:
- Metabolic rate surges (approximately 10-13% increase per 1°C rise): this massively upregulates pyruvate flux through PDHc and alpha-ketoglutarate flux through alpha-KGDH
- The mutant SLC25A19 carrier, already operating at reduced capacity, cannot upregulate TPP import to match demand
- Mitochondrial TPP falls below the Km threshold for PDHc
- Pyruvate accumulates and is shunted to lactate via lactate dehydrogenase
- alpha-KGDH is also impaired, producing alpha-ketoglutaric aciduria (a diagnostic marker)
- Result: acute lactic acidosis + alpha-ketoglutaric aciduria
The paradox: why does high-dose thiamine worsen the acidosis?
This is the mechanistically subtle crux of the question:
Step 1 - What happens when you give high-dose thiamine to a patient with SLC25A19 deficiency:
Exogenous thiamine is rapidly phosphorylated to TPP by cytosolic TPK1. This dramatically increases cytosolic TPP concentration.
Step 2 - The antiporter exchange cycle is partially or completely blocked:
The mutant SLC25A19 carrier transports TPP into the mitochondria by antiporting TMP out. This is a strict exchange - TPP in, TMP out. If the carrier is dysfunctional:
- High cytosolic TPP cannot be imported into the matrix
- Mitochondrial TMP cannot be exported
- The mitochondrial matrix remains TPP-depleted despite massive cytosolic TPP loading
Step 3 - The worsening mechanism has two compounding components:
(a) Substrate push without cofactor delivery:
High-dose thiamine increases cellular glycolytic capacity indirectly - cells respond to perceived "energy availability" signals and upregulate glucose uptake and glycolysis. This generates more pyruvate. But because mitochondrial PDHc still lacks TPP (cannot be imported), this flood of pyruvate cannot be oxidized to acetyl-CoA. It is forced entirely toward lactate. The net effect is a larger pyruvate load driving more lactate production - analogous to the glucose-loading mechanism that worsens lactic acidosis in acquired thiamine deficiency (Wernicke's).
(b) Competitive inhibition of residual transport:
In partial-loss-of-function variants (THMD4, the milder allele), the mutant carrier retains some residual transport activity. High concentrations of cytosolic TPP may actually inhibit the residual import by saturating the carrier at the cytosolic-facing substrate binding site in an unproductive conformation, or by altering the TMP/TPP gradient in a way that makes the antiport thermodynamically unfavorable (reducing the TMP available for export depletes the driving force).
(c) Metabolic re-routing amplification:
TPP is also a cofactor for cytosolic transketolase (pentose phosphate pathway). High cytosolic TPP super-activates transketolase, increasing flux through the pentose phosphate pathway and recycling more NADPH while producing more glycolytic intermediates including pyruvate. This again floods PDHc - which remains TPP-starved inside the mitochondria - with more substrate it cannot process.
In summary of the worsening mechanism:
High-dose thiamine → massive cytosolic TPP accumulation → cannot cross into the matrix (transporter-deficient) → increased glycolytic pyruvate generation from substrate-level effects + no increase in mitochondrial PDHc activity → net increase in pyruvate-to-lactate shunting → worsening acidosis.
When thiamine is withheld, cytosolic TPP falls back to baseline levels, glycolytic pyruvate production normalizes, and the minimal residual PDHc activity (operating with whatever trace TPP reached the matrix by alternative means) is no longer overwhelmed. Acidosis resolves.
Why acidosis completely remits between crises
Between febrile episodes, metabolic demand is at resting basal levels. The mutant carrier, though dysfunctional, retains some residual transport capacity (especially in the milder THMD4 allele - partial loss of function). At resting metabolic rate, even this diminished TPP import is sufficient to maintain adequate mitochondrial TPP concentration to sustain PDHc and alpha-KGDH activity. Pyruvate flux is low enough to be cleared aerobically. There is no lactate accumulation. The patient is biochemically normal.
This pattern - crisis under metabolic stress, complete normalcy at rest - is the hallmark of "threshold" defects in mitochondrial transport: the system is sufficient for basal conditions but collapses during demand surges.
Summary Table
| Feature | Explanation |
|---|---|
| Normal PDH activity in fibroblasts | Assay uses exogenous TPP - bypasses transporter |
| Normal respiratory chain complexes | Structural components are intact |
| Normal pyruvate carboxylase | Uses biotin, not TPP |
| Fever triggers crisis | Increased metabolic demand overwhelms residual TPP import |
| Thiamine worsens acidosis | Cytosolic TPP overload + blocked import → more pyruvate load, no PDH rescue |
| Witholding thiamine improves | Removes cytosolic pyruvate overload stimulus; residual transport handles baseline demand |
| Complete remission between crises | Partial residual transport capacity sufficient at resting metabolic rate |
| Mitochondrial transporter VUS on WES | SLC25A19 - mitochondrial TPP carrier, SLC25 family, chromosome 17q25.1 |
The Specific Transporter: SLC25A19
- Gene: SLC25A19 (chromosome 17q25.1)
- Protein: Mitochondrial thiamine pyrophosphate carrier (MTPPT), also historically called the deoxynucleotide carrier (DNC) - the "DNC" name was a misnomer from early functional studies; TPP is now established as its primary physiological substrate
- Mechanism: Electrogenic antiport of cytosolic TPP for mitochondrial TMP across the inner mitochondrial membrane
- Loss-of-function alleles:
- Severe (null): Amish lethal microcephaly / THMD3 (OMIM 607196) - neonatal onset, severe microcephaly, death in infancy
- Partial: THMD4 (OMIM 613710) - episodic encephalopathy + lactic acidosis with febrile triggers, often with full interictal recovery - this matches the patient described
Differential note on why not TPK1 deficiency
TPK1 deficiency (THMD5) could superficially look similar, but in TPK1 deficiency, giving thiamine (the substrate for TPK1) would actually help or at least not worsen the crisis - because TPK1's deficiency could be partially bypassed with substrate excess. The paradoxical worsening specifically implicates the transporter (SLC25A19), not the kinase, because only when the transport step is blocked does cytosolic TPP accumulation become counterproductive.
Sources: GeneReviews SLC25A19 | UC Davis thiamine metabolism review | Linus Pauling Institute thiamine monograph | Banka et al. (2014) PMID 25458521
This is a shared conversation. Sign in to Orris to start your own chat.